📰
Politics
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
📅24 September 2026 at 23:43
📰Bloomberg
👁️1 views
Share:
📰
Article Preview
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.